No Cover Image

Conference Paper/Proceeding/Abstract 528 views

Discontinuation of Statins and Adverse Clinical Outcomes Post Percutaneous Coronary Intervention

Daniel Harris, Arron S. Lacey Orcid Logo, Ashley Akbari Orcid Logo, Michael Gravenor Orcid Logo, Julian Halcox Orcid Logo

Circulation, Volume: 138, Issue: Suppl_1

Swansea University Authors: Daniel Harris, Arron S. Lacey Orcid Logo, Ashley Akbari Orcid Logo, Michael Gravenor Orcid Logo, Julian Halcox Orcid Logo

Full text not available from this repository: check for access using links below.

Published in: Circulation
ISSN: 0009-7322 1524-4539
Published: 2018
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa54258
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2020-10-12T15:33:32Z
last_indexed 2020-10-13T03:08:32Z
id cronfa54258
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2020-10-12T16:38:27.4598075</datestamp><bib-version>v2</bib-version><id>54258</id><entry>2018-11-06</entry><title>Discontinuation of Statins and Adverse Clinical Outcomes Post Percutaneous Coronary Intervention</title><swanseaauthors><author><sid>e60c9c73b645f0e8033ae26fa8e634b8</sid><firstname>Daniel</firstname><surname>Harris</surname><name>Daniel Harris</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>7af5c8bdd1197f85720e4f3d65e803eb</sid><ORCID>0000-0001-7983-8073</ORCID><firstname>Arron S.</firstname><surname>Lacey</surname><name>Arron S. Lacey</name><active>true</active><ethesisStudent>true</ethesisStudent></author><author><sid>aa1b025ec0243f708bb5eb0a93d6fb52</sid><ORCID>0000-0003-0814-0801</ORCID><firstname>Ashley</firstname><surname>Akbari</surname><name>Ashley Akbari</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>70a544476ce62ba78502ce463c2500d6</sid><ORCID>0000-0003-0710-0947</ORCID><firstname>Michael</firstname><surname>Gravenor</surname><name>Michael Gravenor</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>3676f695eeda169d0f8c618adf27c04b</sid><ORCID>0000-0001-6926-2947</ORCID><firstname>Julian</firstname><surname>Halcox</surname><name>Julian Halcox</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-11-06</date><deptcode>FGMHL</deptcode><abstract/><type>Conference Paper/Proceeding/Abstract</type><journal>Circulation</journal><volume>138</volume><journalNumber>Suppl_1</journalNumber><publisher/><issnPrint>0009-7322</issnPrint><issnElectronic>1524-4539</issnElectronic><keywords/><publishedDay>5</publishedDay><publishedMonth>11</publishedMonth><publishedYear>2018</publishedYear><publishedDate>2018-11-05</publishedDate><doi/><url>https://www.ahajournals.org/doi/10.1161/circ.138.suppl_1.14994</url><notes>https://www.ahajournals.org/doi/10.1161/circ.138.suppl_1.14994</notes><college>COLLEGE NANME</college><department>Medicine, Health and Life Science - Faculty</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>FGMHL</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-10-12T16:38:27.4598075</lastEdited><Created>2018-11-06T00:00:00.0000000</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Daniel</firstname><surname>Harris</surname><order>1</order></author><author><firstname>Arron S.</firstname><surname>Lacey</surname><orcid>0000-0001-7983-8073</orcid><order>2</order></author><author><firstname>Ashley</firstname><surname>Akbari</surname><orcid>0000-0003-0814-0801</orcid><order>3</order></author><author><firstname>Michael</firstname><surname>Gravenor</surname><orcid>0000-0003-0710-0947</orcid><order>4</order></author><author><firstname>Julian</firstname><surname>Halcox</surname><orcid>0000-0001-6926-2947</orcid><order>5</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2020-10-12T16:38:27.4598075 v2 54258 2018-11-06 Discontinuation of Statins and Adverse Clinical Outcomes Post Percutaneous Coronary Intervention e60c9c73b645f0e8033ae26fa8e634b8 Daniel Harris Daniel Harris true false 7af5c8bdd1197f85720e4f3d65e803eb 0000-0001-7983-8073 Arron S. Lacey Arron S. Lacey true true aa1b025ec0243f708bb5eb0a93d6fb52 0000-0003-0814-0801 Ashley Akbari Ashley Akbari true false 70a544476ce62ba78502ce463c2500d6 0000-0003-0710-0947 Michael Gravenor Michael Gravenor true false 3676f695eeda169d0f8c618adf27c04b 0000-0001-6926-2947 Julian Halcox Julian Halcox true false 2018-11-06 FGMHL Conference Paper/Proceeding/Abstract Circulation 138 Suppl_1 0009-7322 1524-4539 5 11 2018 2018-11-05 https://www.ahajournals.org/doi/10.1161/circ.138.suppl_1.14994 https://www.ahajournals.org/doi/10.1161/circ.138.suppl_1.14994 COLLEGE NANME Medicine, Health and Life Science - Faculty COLLEGE CODE FGMHL Swansea University 2020-10-12T16:38:27.4598075 2018-11-06T00:00:00.0000000 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Daniel Harris 1 Arron S. Lacey 0000-0001-7983-8073 2 Ashley Akbari 0000-0003-0814-0801 3 Michael Gravenor 0000-0003-0710-0947 4 Julian Halcox 0000-0001-6926-2947 5
title Discontinuation of Statins and Adverse Clinical Outcomes Post Percutaneous Coronary Intervention
spellingShingle Discontinuation of Statins and Adverse Clinical Outcomes Post Percutaneous Coronary Intervention
Daniel Harris
Arron S. Lacey
Ashley Akbari
Michael Gravenor
Julian Halcox
title_short Discontinuation of Statins and Adverse Clinical Outcomes Post Percutaneous Coronary Intervention
title_full Discontinuation of Statins and Adverse Clinical Outcomes Post Percutaneous Coronary Intervention
title_fullStr Discontinuation of Statins and Adverse Clinical Outcomes Post Percutaneous Coronary Intervention
title_full_unstemmed Discontinuation of Statins and Adverse Clinical Outcomes Post Percutaneous Coronary Intervention
title_sort Discontinuation of Statins and Adverse Clinical Outcomes Post Percutaneous Coronary Intervention
author_id_str_mv e60c9c73b645f0e8033ae26fa8e634b8
7af5c8bdd1197f85720e4f3d65e803eb
aa1b025ec0243f708bb5eb0a93d6fb52
70a544476ce62ba78502ce463c2500d6
3676f695eeda169d0f8c618adf27c04b
author_id_fullname_str_mv e60c9c73b645f0e8033ae26fa8e634b8_***_Daniel Harris
7af5c8bdd1197f85720e4f3d65e803eb_***_Arron S. Lacey
aa1b025ec0243f708bb5eb0a93d6fb52_***_Ashley Akbari
70a544476ce62ba78502ce463c2500d6_***_Michael Gravenor
3676f695eeda169d0f8c618adf27c04b_***_Julian Halcox
author Daniel Harris
Arron S. Lacey
Ashley Akbari
Michael Gravenor
Julian Halcox
author2 Daniel Harris
Arron S. Lacey
Ashley Akbari
Michael Gravenor
Julian Halcox
format Conference Paper/Proceeding/Abstract
container_title Circulation
container_volume 138
container_issue Suppl_1
publishDate 2018
institution Swansea University
issn 0009-7322
1524-4539
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
url https://www.ahajournals.org/doi/10.1161/circ.138.suppl_1.14994
document_store_str 0
active_str 0
published_date 2018-11-05T04:07:40Z
_version_ 1763753549676675072
score 10.998002